These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4969802)

  • 21. [Immunochemical findings about the high molecular weight surface antigens of Shigella sonnei].
    Iarovaia LM; Kovalevskaia IL; Kholchev NV; Shcheglova ES; Korneeva SA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Nov; (11):38-41. PubMed ID: 364891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical studies on protein fractions of Shigella sonnei phase I and phase II.
    Szydlowski S
    Arch Immunol Ther Exp (Warsz); 1968; 16(1):57-72. PubMed ID: 4870683
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemical studies on the specific fragment of Shigella sonnei phase I.
    Romanowska E; Mulczyk M
    Biochim Biophys Acta; 1967 Mar; 136(2):312-9. PubMed ID: 4860559
    [No Abstract]   [Full Text] [Related]  

  • 24. [Production of sera against a thermolabile antigen of Shigella sonnei and their immunoelectrophoretic examinations].
    Kühn H; Kemmer G; Seltmann G
    Z Allg Mikrobiol; 1972; 12(2):127-34. PubMed ID: 4563421
    [No Abstract]   [Full Text] [Related]  

  • 25. The antigenic structure of phase I and II of Sh. sonnei.
    Rauss K; Kontrohr T
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):95-8. PubMed ID: 5338322
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunochemistry of Bothrops venoms. I. Comparative analysis of the antigenic components of 6 species of venoms against their respective antivenins by use of double diffusion and immunoelectrophoresis technics in agar gel].
    Siles Villarroel M; Zelante F; Furlanetto RS; Rolim Rosa R
    Mem Inst Butantan; 1974; 38():13-30. PubMed ID: 4219434
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological properties of lipid A from Shigella sonnei.
    Lugowski C; Romanowska E
    Eur J Biochem; 1974 Oct; 48(1):81-7. PubMed ID: 4614974
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antigenic and tolerogenic properties of Shigella sonnei lipopolysaccharide].
    Borisov VA; Gofman IL
    Mikrobiol Zh (1978); 1981; 43(1):74-7. PubMed ID: 7019631
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenic relationship among virulent enteroinvasive Escherichia coli, Shigella flexneri, and Shigella sonnei detected by ELISA.
    Pál T; Pácsa S; Emödy L; Vörös S
    Lancet; 1983 Jul; 2(8341):102. PubMed ID: 6134933
    [No Abstract]   [Full Text] [Related]  

  • 30. [Shigella surface K-angigens and their role in virulence].
    Belaia IuA; Kostenko LS; Ivanov KK; Petrukhin VG
    Vestn Akad Med Nauk SSSR; 1973; 28(11):35-44. PubMed ID: 4594835
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative studies on the immunologic properties of free endotoxin and lipopolysaccharide from Shigella sonnei.
    Kowalewska D; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):323-30. PubMed ID: 329799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Irradiation sterilization of Shigella sonnei antigens].
    Thilo W; Butte H; Koch W; Weister A
    Z Gesamte Hyg; 1971 Aug; 17(8):615-7. PubMed ID: 4945565
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation, purification and physico-chemical characteristic of Shigella sonnei phase I free endotoxin.
    Romanowska E; Pelczarska A; Wnuk W; Mulczyk M; Godzińska H; Slopek S
    Eur J Biochem; 1970 Feb; 12(3):435-41. PubMed ID: 4985869
    [No Abstract]   [Full Text] [Related]  

  • 34. Laboratory control of oral Shigella sonnei vaccine.
    Starke G; Thilo W
    Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen.
    Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral immunization of mice with Shigella sonnei antigens].
    Thilo W; Weister A
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):294-302. PubMed ID: 4921005
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the epidemiogenic character of some enteropathic colibacilli of the serogroups of O-1 and O-25].
    Buredea M; Beşleagă V; Bercovici C; Tudoranu A; Iosub C; Balaşiu A
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):673-80. PubMed ID: 4921489
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serologic characteristics of the Shigella sonnei mutant rapidly fermenting lactose; antigenic relation between Shigella sonnei phase Il and Shigella boydii 6].
    SZTURM-RUBINSTEN S
    Ann Inst Pasteur (Paris); 1954 Sep; 87(3):342-4. PubMed ID: 13218368
    [No Abstract]   [Full Text] [Related]  

  • 39. 'O'-antigens are essential virulence factors of Shigella sonnei and Shigella dysenteriae 1.
    Binns MM; Vaughan S; Timmis KN
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):197-205. PubMed ID: 2413650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in immunity to its own colicin associated with antigen segregation from phase I to phase II in a wild strain of Shigella sonnei.
    Omori G; Yoshimura A
    Biken J; 1967 Mar; 10(1):33-5. PubMed ID: 4861253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.